267 research outputs found

    Multi Purpose Crew Vehicle Environmental Control and Life Support Development Status

    Get PDF
    The Orion Multi Purpose Crew Vehicle (MPCV) is the first crew transport vehicle to be developed by the National Aeronautics and Space Administration (NASA) in the last thirty years. Orion is currently being developed to transport the crew safely beyond Earth orbit. This year, the vehicle focused on building the Exploration Flight Test 1 (EFT1) vehicle to be launched in 2014. The development of the Orion Environmental Control and Life Support (ECLS) System, focused on the completing the components which are on EFT1. Additional development work has been done to keep the remaining component progressing towards implementation for a flight tests in of EM1 in 2017 and in and EM2 in 2020. This paper covers the Orion ECLS development from April 2012 to April 2013

    Orion Multi-Purpose Crew Vehicle Active Thermal Control and Environmental Control and Life Support Development Status

    Get PDF
    The Orion Multi-Purpose Crew Vehicle (MPCV) is the first crew transport vehicle to be developed by the National Aeronautics and Space Administration (NASA) in the last thirty years. Orion is currently being developed to transport the crew safely beyond Earth orbit. This year, the vehicle focused on building the Exploration Flight Test 1 (EFT1) vehicle to be launched in 2014. The development of the Orion Environmental Control and Life Support (ECLS) System, focused on the completing the components which are on EFT1. Additional development work has been done to keep the remaining component progressing towards implementation for a flight tests in of EM1 in 2017 and in and EM2 in 2020. This paper covers the Orion ECLS development from April 2012 to April 2013

    Orion Multi Purpose Crew Vehicle Environmental Control and Life Support Development Status

    Get PDF
    The Orion Multi Purpose Crew Vehicle (MPCV) is the first crew transport vehicle to be developed by the National Aeronautics and Space Administration (NASA) in the last thirty years. Orion is currently being developed to transport the crew safely from the Earth beyond Earth orbit. This year, the vehicle focused on building the Exploration Flight Test 1 (EFT1) vehicle to be launched in 2014. The development of the Orion Environmental Control and Life Support (ECLS) System, focused on the components which are on EFT1 which includes pressure control and active thermal control systems, is progressing through the design stage into manufacturing. Additional development work was done to keep the remaining component progressing towards implementation for a flight tests in 2017 and in 2020. This paper covers the Orion ECLS development from April 2011 to April 2012

    Crew Exploration Vehicle Environmental Control and Life Support Development Status

    Get PDF
    The Orion Crew Exploration Vehicle (CEV) is the first crew transport vehicle to be developed by the National Aeronautics and Space Administration (NASA) in the last thirty years. The CEV is currently being developed to transport the crew safely from the Earth to the Moon and back again. This year, the vehicle focused on building the Orion Flight Test 1 (OFT1) vehicle to be launched in 2013. The development of the Orion Environmental Control and Life Support (ECLS) System, focused on the components which are on OFT1 which includes pressure control and active thermal control systems, is progressing through the design stage into manufacturing. Additional development work was done to keep the remaining component progressing towards implementation. This paper covers the Orion ECLS development from April 2010 to April 2011

    Orion Multi-Purpose Crew Vehicle Active Thermal Control and Environmental Control and Life Support Development Status

    Get PDF
    The Orion Multi Purpose Crew Vehicle (MPCV) is the first crew transport vehicle to be developed by the National Aeronautics and Space Administration (NASA) in the last thirty years. Orion is currently being developed to transport the crew safely beyond Earth orbit. This year, the vehicle focused on building the Exploration Flight Test 1 (EFT1) vehicle to be launched in September of 2014. The development of the Orion Active Thermal Control (ATCS) and Environmental Control and Life Support (ECLS) System, focused on the integrating the components into the EFT1 vehicle and preparing them for launch. Work also has started on preliminary design reviews for the manned vehicle. Additional development work is underway to keep the remaining component progressing towards implementation on the flight tests of EM1 in 2017 and of EM2 in 2020. This paper covers the Orion ECLS development from April 2013 to April 2014

    Development of Fecal Coliform TMDL Protocols for Bass and Cinder Creeks on Kiawah Island

    Get PDF
    2008 S.C. Water Resources Conference - Addressing Water Challenges Facing the State and Regio

    Aluminium salophen and salen initiators in the ring-opening polymerisation of <em>rac</em>-lactide and <em>rac</em>-β-butyrolactone: Electronic effects on stereoselectivity and polymerisation rates

    Get PDF
    Three aluminium salophen and two aluminium salen complexes were synthesised, characterised and screened in the ring-opening polymerisation (ROP) of rac-lactide and rac-β-butyrolactone. The focus was on controlling the apparent polymerisation rate (k p) and stereoselectivity of poly(lactic acid) and poly(3-hydroxybutyrate) by modulating the electron density at the aluminium centre or by switching from an alkyl backbone (salen complex) to an aryl backbone (salophen complex). The salen complexes generally showed higher k p as well as isoselectivity compared to the salophen complexes. For instance, salophen and salen complexes biased the microstructure of poly(3-hydroxybutyrate) towards syndiotacticity and isotacticity, respectively. Electron-withdrawing or electron-donating backbones on a salophen complex tuned k p, with electron-donating backbones offering faster k p

    Dietary patterns are not associated with disease activity among patients with inflammatory conditions of the pouch in a prospective cohort

    Get PDF
    BACKGROUND: Evidence-based recommendations regarding the influence of diet on inflammatory conditions of the pouch after restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) are limited. METHODS: We analyzed dietary patterns at enrollment in a prospective registry of patients with 1 of 4 inflammatory conditions of the pouch (acute pouchitis, chronic antibiotic-dependent pouchitis, chronic antibiotic refractory pouchitis, and Crohn\u27s disease of the pouch). We analyzed dietary intake by disease activity at enrollment and then compared dietary patterns among patients who remained in remission throughout the 12-month follow-up to those patients who experienced a disease relapse. We also compared dietary patterns among patients with inflammatory conditions of the pouch to the United States Department of Agriculture (USDA) recommended daily goals. RESULTS: Among 308 patients, there were no differences in dietary patterns among patients with 1 of the 4 disease states at enrollment. Additionally, among the 102 patients in remission at baseline, there were no significant differences noted among patients who went on to experience a disease flare in the 12 months after enrollment compared to those patients who remained in remission. However, patients with inflammatory conditions of the pouch demonstrated decreased intake of several food groups and macronutrients including dairy, fruits, vegetables, whole grains, and fiber when compared to USDA recommendations. CONCLUSIONS: In a prospective cohort, we demonstrated no impact of dietary patterns on disease activity. The relative deficiencies in several food groups and macronutrients among patients after IPAA indicate the potential role of targeted nutritional counseling in this population

    Multi Purpose Crew Vehicle Active Thermal Control and Environmental Control and Life Support Development Status

    Get PDF
    The Orion Multi Purpose Crew Vehicle (MPCV) is the first crew transport vehicle to be developed by the National Aeronautics and Space Administration (NASA) in the last thirty years. Orion is currently being developed to transport the crew safely beyond Earth orbit. This year, the vehicle focused on building the Exploration Flight Test 1 (EFT1) vehicle to be launched in September of 2014. The development of the Orion Active Thermal Control (ATCS) and Environmental Control and Life Support (ECLS) System, focused on the integrating the components into the EFT1 vehicle and preparing them for launch. Work also has started on preliminary design reviews for the manned vehicle. Additional development work is underway to keep the remaining component progressing towards implementation on the flight tests of EM1 in 2017 and of EM2 in 2020. This paper covers the Orion ECLS development from April 2013 to April 201

    Treatment patterns and standardized outcome assessments among patients with inflammatory conditions of the pouch in a prospective multicenter registry

    Get PDF
    BACKGROUND: Much of our understanding about the natural history of pouch-related disorders has been generated from selected populations. We designed a geographically diverse, prospective registry to study the disease course among patients with 1 of 4 inflammatory conditions of the pouch. The primary objectives in this study were to demonstrate the feasibility of a prospective pouch registry and to evaluate the predominant treatment patterns for pouch-related disorders. METHODS: We used standardized diagnostic criteria to prospectively enroll patients with acute pouchitis, chronic antibiotic-dependent pouchitis (CADP), chronic antibiotic refractory pouchitis (CARP), or Crohn\u27s disease (CD) of the pouch. We obtained detailed clinical and demographic data at the time of enrollment, along with patient-reported outcome (PRO) measures. RESULTS: We enrolled 318 patients (10% acute pouchitis, 27% CADP, 12% CARP, and 51% CD of the pouch). Among all patients, 55% were on a biologic or small molecule therapy. Patients with CD of the pouch were more likely to use several classes of therapy ( CONCLUSIONS: In a population where most patients had refractory inflammatory conditions of the pouch, we established a framework to evaluate PROs and clinical effectiveness. This infrastructure will be valuable for long-term studies of real-world effectiveness for pouch-related disorders
    corecore